Clinical Trial Update: Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Mayo Clinic is evaluating turkey tail mushroom extract in post-menopausal women with estrogen receptor-positive, HER2-nega…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Turkey Tail Mushroom extract (Trametes versicolor extract)

Snippet

Sponsor: Mayo Clinic | Conditions: Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma | Phase 2 | Status: RECRUITING